MWC
ALXN
MBM Wealth Consultants’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,916
| Closed | -$535K | – | 302 |
|
|
2021
Q2 | $535K | Buy |
2,916
+57
| +2% | +$10.5K | 0.25% | 50 |
|
|
2021
Q1 | $437K | Buy |
2,859
+121
| +4% | +$18.5K | 0.22% | 56 |
|
|
2020
Q4 | $428K | Sell |
2,738
-183
| -6% | -$28.6K | 0.23% | 51 |
|
|
2020
Q3 | $335K | Buy |
2,921
+263
| +10% | +$30.2K | 0.21% | 60 |
|
|
2020
Q2 | $299K | Sell |
2,658
-1,041
| -28% | -$117K | 0.21% | 63 |
|
|
2020
Q1 | $332K | Buy |
3,699
+421
| +13% | +$37.8K | 0.27% | 63 |
|
|
2019
Q4 | $354K | Buy |
3,278
+241
| +8% | +$26K | 0.26% | 71 |
|
|
2019
Q3 | $297K | Buy |
3,037
+208
| +7% | +$20.3K | 0.23% | 75 |
|
|
2019
Q2 | $372K | Buy |
2,829
+167
| +6% | +$22K | 0.31% | 72 |
|
|
2019
Q1 | $360K | Buy |
2,662
+201
| +8% | +$27.2K | 0.32% | 70 |
|
|
2018
Q4 | $240K | Buy |
+2,461
| New | +$240K | 0.23% | 81 |
|